News

Roche and ARIUS Research Inc. today announced that the two companies have signed a definitive agreement for Roche to acquire ARIUS in an all-cash transaction at a price of approximately C$191 ...
Among those roles, Arius understand the immense value in brand positioning, messaging, and marketing strategy so they have secured one of the most brilliant minds in the fintech space. Corey is ...
ARIUS' Trop-2 antibody program targets a novel marker that has been linked in the scientific literature to aggressive cancers including pancreatic, colon, breast and prostate cancer.